These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. β-Amyloid1-42, HIV-1Ba-L (clade B) infection and drugs of abuse induced degeneration in human neuronal cells and protective effects of ashwagandha (Withania somnifera) and its constituent Withanolide A. Kurapati KR; Samikkannu T; Atluri VS; Kaftanovskaya E; Yndart A; Nair MP PLoS One; 2014; 9(11):e112818. PubMed ID: 25415340 [TBL] [Abstract][Full Text] [Related]
3. In vitro protective effects of Withania somnifera (L.) dunal root extract against hydrogen peroxide and β-amyloid(1-42)-induced cytotoxicity in differentiated PC12 cells. Kumar S; Seal CJ; Howes MJ; Kite GC; Okello EJ Phytother Res; 2010 Oct; 24(10):1567-74. PubMed ID: 20680931 [TBL] [Abstract][Full Text] [Related]
4. Improving the inhibition of β-amyloid aggregation by withanolide and withanoside derivatives. Dubey S; Kallubai M; Subramanyam R Int J Biol Macromol; 2021 Mar; 173():56-65. PubMed ID: 33465364 [TBL] [Abstract][Full Text] [Related]
5. Withanoside IV and its active metabolite, sominone, attenuate Abeta(25-35)-induced neurodegeneration. Kuboyama T; Tohda C; Komatsu K Eur J Neurosci; 2006 Mar; 23(6):1417-26. PubMed ID: 16553605 [TBL] [Abstract][Full Text] [Related]
6. Neurodegenerative diseases and Withania somnifera (L.): An update. Dar NJ; Muzamil Ahmad J Ethnopharmacol; 2020 Jun; 256():112769. PubMed ID: 32240781 [TBL] [Abstract][Full Text] [Related]
7. Singh M; Ramassamy C J Nutr Sci; 2017; 6():e54. PubMed ID: 29152258 [TBL] [Abstract][Full Text] [Related]
8. Withania somnifera (L.) Dunal - Modern perspectives of an ancient Rasayana from Ayurveda. Mukherjee PK; Banerjee S; Biswas S; Das B; Kar A; Katiyar CK J Ethnopharmacol; 2021 Jan; 264():113157. PubMed ID: 32783987 [TBL] [Abstract][Full Text] [Related]
9. Effects of Ashwagandha (roots of Withania somnifera) on neurodegenerative diseases. Kuboyama T; Tohda C; Komatsu K Biol Pharm Bull; 2014; 37(6):892-7. PubMed ID: 24882401 [TBL] [Abstract][Full Text] [Related]
10. Dendrite extension by methanol extract of Ashwagandha (roots of Withania somnifera) in SK-N-SH cells. Tohda C; Kuboyama T; Komatsu K Neuroreport; 2000 Jun; 11(9):1981-5. PubMed ID: 10884056 [TBL] [Abstract][Full Text] [Related]
11. Ashwagandha- Withania somnifera (L.) Dunal as a multipotent neuroprotective remedy for genetically induced motor dysfunction and cellular toxicity in human neurodegenerative disease models of Drosophila. Murthy MN; Shyamala BV J Ethnopharmacol; 2024 Jan; 318(Pt A):116897. PubMed ID: 37442493 [TBL] [Abstract][Full Text] [Related]
12. Antihyperalgesic effects of ashwagandha (Withania somnifera root extract) in rat models of postoperative and neuropathic pain. Lim DW; Kim JG; Lim EY; Kim YT Inflammopharmacology; 2018 Feb; 26(1):207-215. PubMed ID: 28849547 [TBL] [Abstract][Full Text] [Related]
13. M1 muscarinic receptor is a key target of neuroprotection, neuroregeneration and memory recovery by i-Extract from Withania somnifera. Konar A; Gupta R; Shukla RK; Maloney B; Khanna VK; Wadhwa R; Lahiri DK; Thakur MK Sci Rep; 2019 Sep; 9(1):13990. PubMed ID: 31570736 [TBL] [Abstract][Full Text] [Related]
14. Multifunctional neuroprotective effect of Withanone, a compound from Withania somnifera roots in alleviating cognitive dysfunction. Pandey A; Bani S; Dutt P; Kumar Satti N; Avtar Suri K; Nabi Qazi G Cytokine; 2018 Feb; 102():211-221. PubMed ID: 29108796 [TBL] [Abstract][Full Text] [Related]